Sort
326,823 grants matching “clinical trial”
Cancer Center Support Grant
$2,290,048Michael J Weber · University Of Virginia · P30 · FY2011 · CA
MIT-Harvard Center of Cancer Nanotechnology Excellence
$2,290,029Robert S Langer · Massachusetts Institute Of Technology · U54 · FY2011 · CA
University of Kentucky Center for Cancer Metabolism
$2,289,653Binhua P Zhou · University Of Kentucky · P20 · FY2023 · GM
University of Kentucky Center for Cancer Metabolism
$2,289,653Binhua P Zhou · University Of Kentucky · P20 · FY2025 · GM
University of Kentucky Center for Cancer Metabolism
$2,289,653Binhua P Zhou · University Of Kentucky · P20 · FY2024 · GM
University of Kentucky Center for Cancer Metabolism
$2,289,653Binhua P Zhou · University Of Kentucky · P20 · FY2022 · GM
DATA CENTER FOR THE ADOLESCENT MEDICINE HIV/AIDS NETWORK
$2,289,634University Of Alabama At Birmingham · U01 · FY2000 · HD
A Proof of Concept Study Examining The Safety and Efficacy of Innate Immune Syste
$2,289,628Owen Hagino · Sanofi Aventis U S, Inc. · UF1 · FY2013 · AG
Center for Molecular Epidemiology
$2,289,580Margaret Rita Karagas · Dartmouth College · P20 · FY2016 · GM
Preventive Vaccines for HIV
$2,289,324Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Genetic and Signaling Pathways in Epithelial Thyroid Cancer
$2,289,198Matthew D Ringel · Ohio State University · P01 · FY2016 · CA
SPORE in Prostate Cancer
$2,289,160William J Catalona · Northwestern University At Chicago · P50 · FY2018 · CA
Randomized Trial of High-Dose Rifampin in Patients with New Smear-Positive TB
$2,289,159Carole D Mitnick · Harvard Medical School · U01 · FY2013 · AI
Flow Cytometry Core
$2,289,001Stephen Perfetto · National Institute Of Allergy And Infectious Diseases · ZIC · FY2024 · AI
Center for the Development of Phenotype-Based Treatments of Autism Spectrum Disorder
$2,288,766David G Amaral · University Of California At Davis · P50 · FY2018 · HD
Air pollution, the social environment, and Alzheimer's disease: Risk and resilience in the Ginkgo Evaluation Memory Study
$2,288,624Joel Daniel Kaufman · University Of Washington · RF1 · FY2017 · AG
Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.
$2,288,273Michael G Agadjanyan · Institute For Molecular Medicine · R01 · FY2025 · AG
DATA CORE (DC)
$2,288,186Ronald G. Thomas · University Of California, San Diego · U01 · FY2008 · AG
NIDCD Core for Clinical Research and Care
$2,288,167Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZID · FY2018 · DC
Exosomes as mediators of cardiac injury and repair
$2,288,095Raj Kishore · Temple Univ Of The Commonwealth · P01 · FY2020 · HL
Chemoprevention of Lung Cancer
$2,288,039Marshall W Anderson · University Of Cincinnati · P01 · FY2007 · CA
T Cell Costimulatory Pathways: Functions and Interactions
$2,287,759Arlene H Sharpe · Harvard Medical School · P01 · FY2017 · AI
Anti-NMDA receptor antibodies in adult brain dsyfunction & fetal brain developmen
$2,287,670Betty Diamond · Feinstein Institute For Medical Research · P01 · FY2014 · AI
Antecedent Biomarkers For AD: The Adult Children Study
$2,287,585John Morris · Washington University · P01 · FY2015 · AG
Look AHEAD: Action for Health in Diabetes
$2,287,341Mark Andrew Espeland · Wake Forest University Health Sciences · U01 · FY2008 · DK